Cargando…

P459 The Aspergillus lateral flow assay for the diagnosis of chronic pulmonary aspergillosis

POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary disease, complicating many other respiratory disorders. Measurement of Aspergillus-specific IgG antibodies had a higher sensitivity than either IgM,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jie, Yan, Jun, Zhang, Yuan, Yao, Wang, Wang, He, Su, Yan, Zhou, Zeqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509893/ http://dx.doi.org/10.1093/mmy/myac072.P459

Ejemplares similares

P460 The Aspergillus Lateral Flow Assay for the diagnosis of invasive Aspergillosis
por: Liu, Chonglong, et al.
Publicado: (2022)

S4.2d Efficacy of LD Bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis
por: Ray, Animesh, et al.
Publicado: (2022)

P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis
por: Hedayati, Mohammad, et al.
Publicado: (2022)

P412 QuicGM Aspergillus Galactomannan Ag lateral flow assay as a practical aid to diagnose invasive Aspergillosis in high-risk hematology patients
por: Aerts, Robina, et al.
Publicado: (2022)

The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

P447 Galactomannan lateral flow assay for the diagnosis of invasive Aspergillosis among clinically suspected patients in tertiary care center, Jodhpur, Rajasthan
por: Priya, Hari, et al.
Publicado: (2022)

Performance of Aspergillus Galactomannan Lateral Flow Assay on Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis
por: Linder, Kathleen A., et al.
Publicado: (2020)

P172 First report of Aspergillus tamarii producing influenza associated invasive pulmonary Aspergillosis
por: Sahu, Monalisa, et al.
Publicado: (2022)

S10.4b Pathophysiology, diagnosis, and management of chronic pulmonary Aspergillosis
por: Izumikawa, Koichi
Publicado: (2022)

Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis
por: Ray, Animesh, et al.
Publicado: (2022)

P436 A study to compare detection of Aspergillus galactomannan in patients with clinically suspected invasive Aspergillosis using the Lateral Flow Assay (LFA) in comparison with Enzyme Linked Immunosorbent Assay (ELISA) and identification of new risk factors as per BM-AspICU criteria
por: Padaki, Priyadarshini, et al.
Publicado: (2022)

257. Aspergillus Galactomannan Lateral Flow Assay for Rapid Diagnosis of Invasive Aspergillosis in Bronchoalveolar Lavage
por: Hoenigl, Martin, et al.
Publicado: (2019)

P453 Aspergillus and aspergillosis in patients in an intensive care unit with mechanical ventilation
por: Trápaga, Mariana, et al.
Publicado: (2022)

P469 Feline aspergillosis caused by Aspergillus candidus: A case report
por: Fernandez, Norma B., et al.
Publicado: (2022)

Diagnostic Laboratory Features and Performance of an Aspergillus IgG Lateral Flow Assay in a Chronic Pulmonary Aspergillosis Cohort
por: Zhu, Rong-Sheng, et al.
Publicado: (2023)

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)

P059 The overexpression of efflux pump gene cdr1B resulting in voriconazole- and isavuconazole- resistance in Aspergillus fumigatus recovered from a patient with chronic pulmonary aspergillosis in China
por: Liang, Tianyu, et al.
Publicado: (2022)

P408 Evaluation of fungal serum biomarkers in the diagnosis and for monitoring patients with post tuberculosis chronic pulmonary aspergillosis
por: Singh, Shreya, et al.
Publicado: (2022)

P428 Evaluation of Galactomannan enzyme assay in non-hematological non-neutropenic ICU admitted patients for diagnosis of Invasive Pulmonary Aspergillosis as per EORTC criteria 2019
por: Kashyap, Sanchi, et al.
Publicado: (2022)

Evaluation of the LDBio Aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis
por: Hunter, Elizabeth Stucky, et al.
Publicado: (2020)

P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022)

Evaluation of LDBio Aspergillus ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis
por: Stucky Hunter, Elizabeth, et al.
Publicado: (2019)

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
por: Heldt, Sven, et al.
Publicado: (2017)

P390 A lateral flow assay for the immunodiagnosis of human cat-transmitted Sporotrichosis
por: Cognialli, Regielly, et al.
Publicado: (2022)

S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria
por: Davies, Adeyinka, et al.
Publicado: (2022)

P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive
por: Setianingrum, Findra, et al.
Publicado: (2022)

P203 Chronic pulmonary aspergillosis (CPA) in post tuberculosis sequele— aclinical experience from tertiary care
por: Gupta, Chhavi, et al.
Publicado: (2022)

P128 Chronic pulmonary aspergillosis in a Tuberculosis c enter of Assam—a 2-year study
por: K, Aishwarya, et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles
por: Fakhim, Hamed, et al.
Publicado: (2022)

P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis
por: Perales-Martinez, Diana, et al.
Publicado: (2022)

P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA)
por: Soman, Rajeev, et al.
Publicado: (2022)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

P141 Study of prevalence, antifungal profile and predictors of mortality in chronic pulmonary Aspergillosis in a cohort of liver disease patient
por: Kale, Pratibha, et al.
Publicado: (2022)

P080 Comparison of efficacy of innovator molecule of itraconazole with generic forms of itraconazole in treatment naïve subjects with chronic pulmonary aspergillosis
por: Sehgal, Inderpaul, et al.
Publicado: (2022)

P143 Incidence of chronic pulmonary aspergillosis in a cohort of bacteriologically confirmed TB patients at a tertiary hospital in Ghana
por: Ocansey, Bright, et al.
Publicado: (2022)

P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022)

Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
por: Salzer, Helmut J. F., et al.
Publicado: (2018)

Evaluation of MycAssay™ Aspergillus for Diagnosis of Invasive Pulmonary Aspergillosis in Patients without Hematological Cancer
por: Guinea, Jesús, et al.
Publicado: (2013)

Evaluation of a commercial quantitative Aspergillus fumigatus-specific IgM assay for the diagnosis of invasive pulmonary aspergillosis
por: Yao, Yake, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6socja5557rokthpp7cfuuh94u